ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...
AAP Newsroom on MSN
Ozempic-style drugs prove to be 'a tailwind' for Resmed
Resmed has beaten expectations with $2 billion in second-quarter revenue and says weight loss drugs are actually boosting ...
Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep apnea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results